Aydin Huseynov is an analyst at Ladenburg Thalmann. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/16/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 05/14/2024 | CAPR | Buy Now | Capricor Therapeutics | $5.20 | 380.77% | $24 → $25 | Maintains | Buy | Get Alert |
| 04/30/2024 | MRKR | Buy Now | Marker Therapeutics | $4.25 | 158.82% | → $11 | Initiates | → Buy | Get Alert |
| 04/29/2024 | ACRV | Buy Now | Acrivon Therapeutics | $8.65 | — | — | Downgrade | Buy → Neutral | Get Alert |
| 04/18/2024 | ALRN | Buy Now | Aileron Therapeutics | $3.84 | 394.79% | $9 → $19 | Maintains | Buy | Get Alert |
| 04/05/2024 | ACRV | Buy Now | Acrivon Therapeutics | $8.65 | 61.85% | $18 → $14 | Maintains | Buy | Get Alert |
| 03/14/2024 | SPRB | Buy Now | Spruce Biosciences | $0.78 | — | — | Downgrade | Buy → Neutral | Get Alert |
| 02/08/2024 | BDRX | Buy Now | Biodexa Pharmaceuticals | $1.17 | 583.76% | → $8 | Initiates | → Buy | Get Alert |
| 12/27/2023 | PMVP | Buy Now | PMV Pharma | $2.16 | 224.07% | → $7 | Initiates | → Buy | Get Alert |
| 12/01/2023 | ALRN | Buy Now | Aileron Therapeutics | $3.84 | 134.38% | → $9 | Upgrade | Neutral → Buy | Get Alert |
| 10/10/2023 | ZURA | Buy Now | Zura Bio | $4.94 | 102.43% | → $10 | Initiates | → Buy | Get Alert |
| 09/22/2023 | COEP | Buy Now | Coeptis Therapeutics | $0.33 | 799.55% | → $3 | Initiates | → Buy | Get Alert |
| 08/14/2023 | CGTX | Buy Now | Cognition Therapeutics | $1.90 | 215.79% | $10 → $6 | Maintains | Buy | Get Alert |
| 06/05/2023 | ATHE | Buy Now | Alterity Therapeutics | $2.07 | 383.09% | $20 → $10 | Maintains | Buy | Get Alert |
| 05/30/2023 | CRVS | Buy Now | Corvus Pharma | $2.23 | 348.43% | $4 → $10 | Maintains | Buy | Get Alert |
| 05/16/2023 | PALI | Buy Now | Palisade Bio | $5.88 | 172.11% | $375 → $240 | Maintains | Buy | Get Alert |
| 04/28/2023 | TPST | Buy Now | Tempest Therapeutics | $3.36 | 316.67% | $8 → $14 | Maintains | Buy | Get Alert |
| 04/04/2023 | PCSA | Buy Now | Processa Pharma | $2.02 | 98.02% | $180 → $80 | Maintains | Speculative Buy | Get Alert |
| 03/07/2023 | ADVM | Buy Now | Adverum Biotechnologies | $8.75 | -77.14% | → $20 | Initiates | → Buy | Get Alert |
| 12/07/2022 | NRBO | Buy Now | NeuroBo Pharmaceuticals | $3.90 | 53.8% | → $48 | Initiates | → Buy | Get Alert |
| 11/15/2022 | CALA | Buy Now | Calithera Biosciences | $0.02 | — | — | Downgrade | Buy → Neutral | Get Alert |
| 11/04/2022 | NXTC | Buy Now | NextCure | $1.64 | — | — | Downgrade | Buy → Neutral | Get Alert |
| 10/26/2022 | CAPR | Buy Now | Capricor Therapeutics | $5.20 | 188.46% | → $15 | Initiates | → Buy | Get Alert |
| 10/07/2022 | CRVS | Buy Now | Corvus Pharma | $2.23 | -10.31% | → $2 | Initiates | → Buy | Get Alert |
| 09/15/2022 | TPST | Buy Now | Tempest Therapeutics | $3.36 | 138.1% | → $8 | Initiates | → Buy | Get Alert |
| 08/31/2022 | STSA | Buy Now | Satsuma Pharma | — | — | → $16 | Initiates | → Buy | Get Alert |
| 08/23/2022 | ALLR | Buy Now | Allarity Therapeutics | $0.68 | — | — | Downgrade | Buy → Neutral | Get Alert |
| 08/03/2022 | ATHE | Buy Now | Alterity Therapeutics | $2.07 | -3.38% | → $20 | Initiates | → Buy | Get Alert |
| 07/27/2022 | ANEB | Buy Now | Anebulo Pharmaceuticals | $2.36 | 154.24% | → $6 | Initiates | → Buy | Get Alert |
| 07/13/2022 | NVCT | Buy Now | Nuvectis Pharma | $6.65 | 215.79% | → $21 | Initiates | → Buy | Get Alert |
| 05/27/2022 | ALLR | Buy Now | Allarity Therapeutics | $0.68 | 1076.47% | → $224000 | Initiates | → Buy | Get Alert |
| 05/06/2022 | QNRX | Buy Now | Quoin Pharmaceuticals | $0.78 | 156.41% | → $300 | Initiates | → Buy | Get Alert |
| 05/02/2022 | ANVS | Buy Now | Annovis Bio | $8.72 | 324.31% | → $37 | Initiates | → Buy | Get Alert |
| 04/22/2022 | CGTX | Buy Now | Cognition Therapeutics | $1.90 | 426.32% | → $10 | Initiates | → Buy | Get Alert |
| 03/15/2022 | CMPX | Buy Now | Compass Therapeutics | $1.54 | 354.55% | → $7 | Initiates | → Buy | Get Alert |
| 03/08/2022 | SPRB | Buy Now | Spruce Biosciences | $0.78 | 668.15% | → $6 | Initiates | → Buy | Get Alert |
| 03/01/2022 | NXTC | Buy Now | NextCure | $1.64 | 875.61% | → $16 | Initiates | → Buy | Get Alert |
| 02/16/2022 | BLCM | Buy Now | Bellicum Pharmaceuticals | $0.07 | 6588.96% | → $5 | Initiates | → Buy | Get Alert |
| 02/02/2022 | PALI | Buy Now | Palisade Bio | $5.88 | -14.97% | → $3750 | Initiates | → Buy | Get Alert |
| 01/31/2022 | CALA | Buy Now | Calithera Biosciences | $0.02 | 19900% | → $80 | Initiates | → Buy | Get Alert |
| 12/10/2021 | SPRB | Buy Now | Spruce Biosciences | $0.78 | 796.17% | — | Initiates | → Speculative Buy | Get Alert |
| 11/17/2021 | TRIL | Buy Now | Trillium Therapeutics | — | — | — | Downgrade | Buy → Hold | Get Alert |
| 05/21/2020 | INO | Buy Now | Inovio Pharmaceuticals | $13.01 | 115.22% | → $336 | Initiates | → Buy | Get Alert |
